Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
Authors: Tiong IS; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.; Guy's Hospital, London, United Kingdom., Ivey A; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Kuzich JA; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia., Thiagarajah N; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Sharplin KM; Royal Adelaide Hospital, Adelaide, SA, Australia., Kok CH; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Tedjaseputra A; Monash Health, Melbourne, VIC, Australia., Rowland JP; Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Grove CS; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia., Abro E; Princess Alexandra Hospital, Woolloongabba, QLD, Australia., Shortt J; Monash Health, Melbourne, VIC, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Hiwase DK; Royal Adelaide Hospital, Adelaide, SA, Australia., Bajel A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Potter NE; Department of Medical and Molecular Genetics, King's College, London, United Kingdom., Smith ML; Department of Haematology, St. Bartholomew's Hospital, London, United Kingdom., Hemmaway CJ; Department of Haematology, Auckland City Hospital, Auckland, New Zealand; and., Thomas A; Centre for Trials Research and., Gilkes AF; Department of Haematology, Cardiff University, Cardiff, United Kingdom., Russell NH; Guy's Hospital, London, United Kingdom., Wei AH; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Source: Blood advances [Blood Adv] 2021 Dec 14; Vol. 5 (23), pp. 5107-5111.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2021005455